Outcome of the Board Meeting held on August 28, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Welcure Drugs & Pharmaceuticals, which met on August 28, 2025, approved plans to raise up to Rs. 80 crores through a Qualified Institutions Placement (QIP) by issuing equity shares. The fundraising will happen in one or more tranches and is subject to shareholder approval via postal ballot. The board also approved the appointment of a merchant banker and constituted a three-member QIP Committee led by Ravi Thakor as Chairman to oversee the issue. Pricing details and the exact number of shares to be issued will be determined later under applicable SEBI rules.
This is an equity fundraising move that may dilute existing shareholders once shares are allotted. Short-term stock sentiment may depend on the eventual issue price versus the current market price; details on pricing and timing are still awaited.